Compugen (CGEN) Tops Q4 EPS by 68c
Tweet
Share
E-mailGet Alerts CGEN Hot Sheet
Join SI Premium – FREE
Compugen (NASDAQ: CGEN) reported Q4 EPS of $0.60, $0.68 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $67.33 million.
For earnings history and earnings-related data on Compugen (CGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Equities Haul To Rip Past $5 Billion Toward New Record - Bloomberg
- Bernstein SocGen's Thoughts on Abbvie (ABBV) Following APGE Acquisition
- Simulations Plus uses Nvidia BioNeMo toolkit for drug development AI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
